Preeminent Oncolocy Clinicians from Leading Cancer Centers Join...

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced the establishment of its Scientific Advisory Board for Iomab-B comprised of several preeminent clinicians in the fields of oncology, hematology, and bone marrow transplant .

http://ift.tt/1lRVUWd